Season 2 Episode 26: The Battle of PTSD featuring Epivario | Growing Greater

This week on the podcast we learn about an early-stage biopharma discovery and development company called Epivario. Founded by epigeneticists at the University of Pennsylvania, Epivario works on new treatments for a wide range of memory-related psychiatric disorders like PTSD, Alzheimer’s, and alcohol and drug addiction. President and CEO at Epivario, Thomas Kim, sat down with Matt Cabrey, Executive Director of Select Greater Philadelphia, a council of the Chamber of Commerce for Greater Philadelphia and shared how they are navigating the regulatory space as they continue to grow.